Status:
COMPLETED
Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program
Lead Sponsor:
Universidad de Granada
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
The aim of this study is to determine if therapeutic exercise before anticancer treatment will mitigate the onset or extent of cardiotoxicity comparing to therapeutic exercise performed during antican...
Detailed Description
The positive relationship between physical exercise and cancer is widely justified in the literature, but an emerging research line warns of its capacity to improve the effectiveness and reduce the to...
Eligibility Criteria
Inclusion
- 18 years or older
- Breast cancer diagnosis I-III stage
- On the waiting list to anticancer medical treatment (at least surgery, chemotherapy and radiotherapy.
- If they meet other criteria which predisposes to higher toxicity.
- Have signed informed consent.
- Have medical clearance for participation.
Exclusion
- Patient underwent previous cancer treatments.
- Patients were previously diagnosed with cancer.
- Pregnant patients.
- Patients performing other type of therapeutic exercise at diagnosis time with an intake \>or = to 150 moderate-intensity or 75 min of vigorous-intensity a day.
- Therapeutic exercise practice not recommended because psychiatric or cognitive disorders or cute or chronic condition that prevents exercise (advanced lung disease, oxygen requirement, stenosis \>70%, metastasis etc.).
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03787966
Start Date
September 1 2019
End Date
November 14 2025
Last Update
November 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Granada
Granada, Spain, 18016